Mitochondrial quality control in cardiac ischemia/reperfusion injury: new insights into mechanisms and implications
- PMID: 35951200
- DOI: 10.1007/s10565-022-09716-2
Mitochondrial quality control in cardiac ischemia/reperfusion injury: new insights into mechanisms and implications
Abstract
The current effective method for the treatment of myocardial infarction is timely restoration of the blood supply to the ischemic area of the heart. Although reperfusion is essential for reestablishing oxygen and nutrient supplies, it often leads to additional myocardial damage, creating an important clinical dilemma. Reports from long-term studies have confirmed that mitochondrial damage is the critical mechanism in cardiac ischemia/reperfusion (I/R) injury. Mitochondria are dynamic and possess a quality control system that targets mitochondrial quantity and quality by modifying mitochondrial fusion, fission, mitophagy, and biogenesis and protein homeostasis to maintain a healthy mitochondrial network. The system of mitochondrial quality control involves complex molecular machinery that is highly interconnected and associated with pathological changes such as oxidative stress, calcium overload, and endoplasmic reticulum (ER) stress. Because of the critical role of the mitochondrial quality control systems, many reports have suggested that defects in this system are among the molecular mechanisms underlying myocardial reperfusion injury. In this review, we briefly summarize the important role of the mitochondrial quality control in cardiomyocyte function and focus on the current understanding of the regulatory mechanisms and molecular pathways involved in mitochondrial quality control in cardiac I/R damage.
Keywords: Mitochondrial biogenesis; Mitochondrial dynamics; Mitochondrial quality control; Mitochondrial unfolded protein response; Mitophagy; Myocardial I/R injury.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Mitochondrial scenario: roles of mitochondrial dynamics in acute myocardial ischemia/reperfusion injury.J Recept Signal Transduct Res. 2021 Feb;41(1):1-5. doi: 10.1080/10799893.2020.1784938. Epub 2020 Jun 25. J Recept Signal Transduct Res. 2021. PMID: 32583708 Review.
-
Mitophagy and mitochondrial integrity in cardiac ischemia-reperfusion injury.Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2293-2302. doi: 10.1016/j.bbadis.2019.05.007. Epub 2019 May 14. Biochim Biophys Acta Mol Basis Dis. 2019. PMID: 31100337 Review.
-
Tongmai formula improves cardiac function via regulating mitochondrial quality control in the myocardium with ischemia/reperfusion injury.Biomed Pharmacother. 2020 Dec;132:110897. doi: 10.1016/j.biopha.2020.110897. Epub 2020 Oct 28. Biomed Pharmacother. 2020. PMID: 33113431
-
Mitochondrial LonP1 protects cardiomyocytes from ischemia/reperfusion injury in vivo.J Mol Cell Cardiol. 2019 Mar;128:38-50. doi: 10.1016/j.yjmcc.2018.12.017. Epub 2019 Jan 6. J Mol Cell Cardiol. 2019. PMID: 30625302
-
The Role of Mitochondrial Quality Control in Cardiac Ischemia/Reperfusion Injury.Oxid Med Cell Longev. 2021 Jun 9;2021:5543452. doi: 10.1155/2021/5543452. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34211627 Free PMC article. Review.
Cited by
-
Involvement of Oxidative Stress and Antioxidants in Modification of Cardiac Dysfunction Due to Ischemia-Reperfusion Injury.Antioxidants (Basel). 2025 Mar 14;14(3):340. doi: 10.3390/antiox14030340. Antioxidants (Basel). 2025. PMID: 40227421 Free PMC article. Review.
-
Shen-fu Injection Modulates HIF- 1α/BNIP3-Mediated Mitophagy to Alleviate Myocardial Ischemia-Reperfusion Injury.Cardiovasc Toxicol. 2025 Jun;25(6):898-914. doi: 10.1007/s12012-025-09993-3. Epub 2025 Apr 17. Cardiovasc Toxicol. 2025. PMID: 40246789
-
Beyond Paradox: Ozone Therapy as a Hormetic Modulator in Ischemia-Reperfusion Injury - An Update.Cell Biochem Biophys. 2025 Jul 10. doi: 10.1007/s12013-025-01824-0. Online ahead of print. Cell Biochem Biophys. 2025. PMID: 40640585 Review.
-
Therapeutic potential and mechanistic insights of astragaloside IV in the treatment of arrhythmia: a comprehensive review.Front Pharmacol. 2025 Apr 10;16:1528208. doi: 10.3389/fphar.2025.1528208. eCollection 2025. Front Pharmacol. 2025. PMID: 40276608 Free PMC article. Review.
-
Caveolin-3: therapeutic target for diabetic myocardial ischemia/reperfusion injury.Mol Med. 2025 Feb 26;31(1):80. doi: 10.1186/s10020-025-01117-5. Mol Med. 2025. PMID: 40012041 Free PMC article. Review.
References
-
- Adaniya SM, O-uchi J, Cypress MW, Kusakari Y, Jhun BS. Posttranslational modifications of mitochondrial fission and fusion proteins in cardiac physiology and pathophysiology. Am J Physiol Cell Physiol. 2019;C316:C583–604. https://doi.org/10.1152/ajpcell.00523.2018 . - DOI
-
- Akimoto T, Pohnert SC, Li P, Zhang M, Gumbs C, Rosenberg PB, et al. Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway. J Biol Chem. 2005;280:19587–93. https://doi.org/10.1074/jbc.M408862200 . - DOI - PubMed
-
- Anzell AR, Maizy R, Przyklenk K, Sanderson TH. Mitochondrial quality control and disease: insights into ischemia-reperfusion injury. Mol Neurobiol. 2018;55:2547–64. https://doi.org/10.1007/s12035-017-0503-9 . - DOI - PubMed
-
- Baetz D, Regula KM, Ens K, Shaw J, Kothari S, Yurkova N, et al. Nuclear factor-kappaB-mediated cell survival involves transcriptional silencing of the mitochondrial death gene BNIP3 in ventricular myocytes. Circulation. 2005;112:3777–85. https://doi.org/10.1161/circulationaha.105.573899 . - DOI - PubMed
-
- Bai Y, Yang Y, Gao Y, Lin D, Wang Z, Ma J. Melatonin postconditioning ameliorates anoxia/reoxygenation injury by regulating mitophagy and mitochondrial dynamics in a SIRT3-dependent manner. Eur J Pharmacol. 2021;904: 174157. https://doi.org/10.1016/j.ejphar.2021.174157 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical